← Open Payments lookup

JENNIFER BURR: Open Payments

NPI 1528290988 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$441 in 20 payments from 10 companies in 2025. Trend: 2023 $835 · 2024 $343 · 2025 $441

Food & beverage: $441
CompanyPaymentsAmount
BridgeBio Pharma, Inc.3$71
Boehringer Ingelheim Pharmaceuticals, Inc.3$71
HEARTFLOW, INC.3$66
Novo Nordisk Inc2$54
E.R. Squibb & Sons, L.L.C.3$54
PFIZER INC.2$35
Alnylam Pharmaceuticals Inc.1$29
Esperion Therapeutics, Inc.1$27
AstraZeneca Pharmaceuticals LP1$18
Lilly USA, LLC1$16

Products named: Attruby, JARDIANCE, FFRct, CAMZYOS, ELIQUIS, Ozempic, AMVUTTRA, NEXLETOL.

Industry payments across NY — which companies pay providers there.